Effectiveness of Mechano-Analgesia and Cold Application on Ecchymosis, Pain and Satisfaction at Subcutaneous Heparin Injection

NCT ID: NCT03645369

Last Updated: 2018-08-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

165 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-02

Study Completion Date

2015-12-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Fifty-five patients received three subcutaneous heparin injections (165 injections) by the same investigator using additional techniques such as mechano-analgesia and cold application, and without any additional techniques.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The abdomen was divided into four quarters. The first, second, and third SC heparin injections were applied from the right abdominal region using ShotBlocker®, left abdominal region with an ice pack, and lower abdominal region without any additional application, respectively. All the injection sites were circled using a skin marking pen (r = 5 cm).

All the injections were administered following a standard procedure. Pain and satisfaction were assessed immediately after the injection by using the VAS score. Ecchymosis was assessed with an ecchymosis measurement tool at 48 and 60 hours after the injection (Figure 3).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Injection Site Reaction Injection Site Bruising

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants
This study was conducted on receiving treatment patients in the Orthopedics and Traumatology wards of a university hospital.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mechano-Analgesia

The first SC heparin injections were applied from the right abdominal region using ShotBlocker®.

Group Type EXPERIMENTAL

ShotBlocker

Intervention Type DEVICE

ShotBlocker is a drug-free tool with no side effects and does not require preparation. It is a flexible, plastic, C-shaped device with a number of short (2 mm) blunt contact points on its back.

Cold Application

The second SC heparin injections were applied from the left abdominal region with an ice pack

Group Type EXPERIMENTAL

Ice pack

Intervention Type DEVICE

Ice pack containing gel

Control

The second SC heparin injections were applied from the lower abdominal region without any additional application

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ShotBlocker

ShotBlocker is a drug-free tool with no side effects and does not require preparation. It is a flexible, plastic, C-shaped device with a number of short (2 mm) blunt contact points on its back.

Intervention Type DEVICE

Ice pack

Ice pack containing gel

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must be older than 18 years
* Open to communication
* No complications during the operation
* Normal body mass index (BMI; reference range, 18.5-29.9 kg/m2) (d) and
* Platelet count (150.000-300.000)
* Give consent to participate in the study

Exclusion Criteria

* Oral and parenteral anticoagulant treatment for at least 5 days
* Infection, scar tissue or incision, and parenteral treatment in their abdominal area
* Hematological and allergic disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul Saglik Bilimleri University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Demet İnangil, PhD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

References

Explore related publications, articles, or registry entries linked to this study.

Celik N, Khorshid L. The Use of ShotBlocker for Reducing the Pain and Anxiety Associated With Intramuscular Injection: A Randomized, Placebo Controlled Study. Holist Nurs Pract. 2015 Sep-Oct;29(5):261-71. doi: 10.1097/HNP.0000000000000105.

Reference Type RESULT
PMID: 26263287 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

108400987-67

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

IM İnjection-PAIN-Cold Spray and Stress Ball
NCT07233694 NOT_YET_RECRUITING NA